- Home
- TSLX vs VCYT Comparison
TSLX vs VCYT Comparison
Compare TSLX & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSLX
- VCYT
- Stock Information
- Founded
- TSLX 2010
- VCYT 2006
- Country
- TSLX United States
- VCYT United States
- Employees
- TSLX N/A
- VCYT N/A
- Industry
- TSLX Investment Managers
- VCYT Medical Specialities
- Sector
- TSLX Finance
- VCYT Health Care
- Exchange
- TSLX Nasdaq
- VCYT Nasdaq
- Market Cap
- TSLX 2.2B
- VCYT 2.4B
- IPO Year
- TSLX 2014
- VCYT 2013
- Fundamental
- Price
- TSLX $23.40
- VCYT $31.83
- Analyst Decision
- TSLX Buy
- VCYT Buy
- Analyst Count
- TSLX 9
- VCYT 9
- Target Price
- TSLX $23.39
- VCYT $39.89
- AVG Volume (30 Days)
- TSLX 354.1K
- VCYT 921.3K
- Earning Date
- TSLX 11-04-2025
- VCYT 11-05-2025
- Dividend Yield
- TSLX 8.83%
- VCYT N/A
- EPS Growth
- TSLX N/A
- VCYT N/A
- EPS
- TSLX 2.01
- VCYT 0.34
- Revenue
- TSLX $474,291,000.00
- VCYT $479,129,000.00
- Revenue This Year
- TSLX N/A
- VCYT $14.19
- Revenue Next Year
- TSLX N/A
- VCYT $9.68
- P/E Ratio
- TSLX $11.68
- VCYT $95.21
- Revenue Growth
- TSLX 0.15
- VCYT 19.91
- 52 Week Low
- TSLX $18.58
- VCYT $22.61
- 52 Week High
- TSLX $25.17
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- TSLX 36.66
- VCYT 58.59
- Support Level
- TSLX $23.14
- VCYT $30.67
- Resistance Level
- TSLX $24.76
- VCYT $32.34
- Average True Range (ATR)
- TSLX 0.34
- VCYT 1.18
- MACD
- TSLX -0.15
- VCYT -0.06
- Stochastic Oscillator
- TSLX 15.76
- VCYT 73.71
About TSLX Sixth Street Specialty Lending Inc.
Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.